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The main goal of this research is to see how propionate, a common food preservative and an important 
metabolite in humans, alters the activation of our immune system. The effects of propionate on macrophage 
activation will be determined by using nitrite and LDH assays. For these assays, different concentrations of 
propionate will be tested to determine how macrophages respond to the activation by LPS and interferon 
gamma. Another goal of this project is to determine the effects of propionate and macrophage activation on 
intracellular survival of L. monocytogenes. A gentamicin protection assay will be used to better establish 
the role of multiple variables related to L. monocytogenes infection. These variables include the length and 
level of propionate exposure prior to infection, macrophage activation state, and nitric oxide production. 
From these experiments we investigated if over stimulation of anti-inflammatory SCFAs could lead to an 
increase of susceptibility to L. monocytogenes infections. Results from these proposed experiments will 
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 The main goal of this research project is to determine the role of propionate in the 
antimicrobial functions of macrophages against the intracellular pathogen Listeria 
monocytogenes. It is important to gain a greater understanding into how the immune 
system is regulated by different environmental factors that are present in the body. 
Specifically, for this research, the effect of propionate on the immune system is examined 
as it is one of the dominant short chain fatty acids (SCFAs) present in the gut during L. 
monocytogenes infection. Further research into the effect of propionate on the immune 
system will help determine if it could be used in a clinical setting to treat or prevent L. 
monocytogenes and other infectious diseases.  
We want to see if propionate can be used to naturally enhance our immune 
responses before and during infection. If the data supports this claim, then propionate 
could be used as a preventative measure before infection and could be used as a treatment 
during an infection in conjunction with, or instead of, antibiotics. It is important to 
establish other treatment options besides the primary use of antibiotics to the increasing 
amounts of antibiotics resistant infections that are emerging. According to the CDC, 28 
million people in the U.S. suffer from an antibiotic resistant infection and 35,000 of those 
people die from these infections each year1. Increasing antibiotic resistance is due in part 
to the overuse and misuse of antibiotics, which includes taking antibiotics for viral 
infections, not finishing taking your antibiotics when you have an infection and by using 
old, expired antibiotics from previous infections2. Additionally, incidence of antibiotic 
resistance is also increasing because of the overuse of antibiotics in the manufacturing of 
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the foods we eat, including livestock and crops. This can lead to the spread of antibiotic 
resistant pathogens that are difficult to treat with the antibiotic options that we have 
available1. 
Therefore, as some infections become harder to treat successfully with antibiotics, it is 
important to look into other treatment options. Specifically, in this research we are trying 
to see if propionate could be used as a better, noninvasive, and cheaper alternative to 
antibiotics that could prevent unnecessary deaths from antibiotic resistant infections in 
the United States. In this research the pathogen L. monocytogenes was used to establish 
the effects of propionate on the immune system during infection. Although L. 
monocytogenes is not typically considered an antibiotic resistant pathogen3, it serves as a 
good infection model to better understand how propionate and other environmental 
factors can be used to modulate our immune response. 
Listeria monocytogenes 
 L. monocytogenes is a Gram-positive bacterium and an opportunistic pathogen for 
a variety of mammals. Listeria infection is most likely to occur in immunocompromised 
individuals, pregnant women, and the elderly. 
According to the Center for Disease Control, 
approximately 1,600 people get infected by L. 
monocytogenes and about 260 of those die from 
infection each year4. Therefore, although L. 
monocytogenes infections are rare, the high 






Figure 1. A schematic showing key steps and 
virulence factors in L. monocytogenes 
intracellular life cycle. (Image credit: reference 
[5]) 
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infections argue for a better understanding of the disease mechanisms to identify more 
effective preventative measures.  
Intracellular Life Cycle of Listeria monocytogenes 
 L. monocytogenes is an intracellular pathogen that is able to survive and replicate inside 
host cells, such as macrophages. L. monocytogenes has a specific intracellular life cycle to 
be able to grow in macrophages and to spread to neighboring cells. In the intracellular life 
cycle of L. monocytogenes (Figure 1)5, surface proteins InlA and InlB are used to aid the 
entry of L. monocytogenes into the host cell. Once inside the host cell, pore forming toxin 
listeriolysin O (LLO) and phospholipase C are used to help L. monocytogenes escape from 
the vacuole and into the cytosol. After the entry of the bacteria into the cytosol, L. 
monocytogenes induces the polymerization of host actin filaments to form actin rockets 
that allow L. monocytogenes to move from cell to cell.  
Antimicrobial Functions of Macrophages 
Macrophages are professional phagocytes that are important for detecting and 
eliminating foreign materials. These cells can circulate throughout our body as well as 
staying within specific tissues. They act as a major line of defense against bacterial 
pathogens by providing a variety of antimicrobial functions. As phagocytes, macrophages 
can engulf pathogens into intracellular phagosomes where degradation of the pathogen 
takes place. For example, inducible nitric oxide synthase (iNOS) in macrophages 
catalyzes the production of nitric oxide (NO), which contain both direct and indirect 
antimicrobial effects6. NO is an inflammatory molecule that is able to directly damage 
bacterial enzymes, resulting in decreased bacterial fitness and growth. Indirect effects of 
NO occur when NO reacts with reactive oxygen species to general additional oxidative 
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stress for the intracellular bacteria. When NO is diffused into the lumen of phagosomes, it 
reacts with superoxide to form peroxynitrite (ONOO-)6, which modifies bacterial proteins 
and DNA to further intoxicate the ingested microbes. Together, these oxygen and 
nitrogen radicals provide a strong oxidative defense against engulfed pathogens.  
Activation of NO Production in Macrophages Against Listeria 
monocytogenes 
 The production of NO is tightly regulated in macrophages partly through the 
regulation on the expression of iNOS. In the presence of pro-inflammatory cytokines 
(such as interferon gamma) and bacterial ligands (such as lipopolysaccharides), naive 
macrophages are activated so that genes relevant to antimicrobial activities or 
inflammation are upregulated. Expectedly, intracellular growth of L. monocytogenes in 
activated bone marrow-derived macrophages (BMDMs) was significantly compromised 
compared to growth in naive BMDMs7. Specifically, for iNOS, increased levels of NO in 
BMDM were shown to prevent the escape of L. monocytogenes from the vacuole into the 
cytoplasm7. Moreover, in another study, increased localization of iNOS in the phagosome 
of activated BMDMs by a deubiquitinase (DUB) inhibitor resulted in enhanced killing of 
intracellular L. monocytogenes8.  
Short Chain Fatty Acids 
Numerous other physiological signals also contribute to the regulation of 
macrophage activities, potentially influencing infection outcomes. For example, short 
chain fatty acids (SCFAs) have been reported to exhibit anti-inflammatory effects9 and 
can potentially alter L. monocytogenes infections in macrophages. In the intestinal lumen, 
SCFAs are a subset of fatty acids with less than six carbon atoms. SCFAs, such as 
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propionate, butyrate, and acetate, are produced in the gut microbiota from the bacterial 
fermentation of hard to digest foods such as dietary fibers10. Our lab has previously 
shown that propionate, one of the dominant SCFAs, exhibits a strong effect on L. 
monocytogenes fitness and toxin production11. Because SCFA levels are heavily 
influenced by an individual’s diet12, understanding the function of SCFAs presents a 
unique opportunity to use noninvasive, dietary measures to prevent L. monocytogenes 
infections. Alternatively, this understanding will also help us identify if there are dietary 
regimens that can potentially increase susceptibility to L. monocytogenes infections and 
need to be avoided for high-risk individuals. Specifically, propionate could be used as a 
food additive or supplement to enhance the immune response and prevent infection by 
infectious diseases. For my thesis research, I am hypothesizing that if SCFAs are anti-
inflammatory, exposure to SCFAs by macrophages might lead to a reduced NO 
production, allowing the growth of more intracellular L. monocytogenes. If this were true, 
despite the known health benefits of SCFAs9, over-stimulation of SCFA production 
might pose a potential threat to increasing individual susceptibility to L. monocytogenes 
infections. Therefore, my honors thesis focuses on determining the role of propionate, 




Listeria monocytogenes Culture  
For this research the wild type 10403s Listeria monocytogenes bacterial strain 
was cultured overnight (15-18 hours) in 2 mL of filter sterilized brain heart infusion 
Page | 6 
 
 
(BHI) media. For each culture, 1-2 colonies were placed into the media. The aerobic L. 
monocytogenes cultures were incubated at 37°C and agitated at 250 rpm. The anaerobic 
L. monocytogenes cultures were also incubated at 37°C, but they were placed inside an 
anaerobic chamber (COY Laboratory) and were not shaken. The environment of the 
anaerobic chamber consisted of nitrogen and about 2.5% hydrogen.  
 
RAW264.7 Macrophage Culture  
RAW264.7 mouse peritoneal macrophage cell line (ATCC) were cultured in 
Dulbecco’s Modified Eagle Medium (DMEM) (VWR) with 10% (v/v) fetal bovine serum 
(Fisher Scientific) and penicillin-streptomycin (5000 µg/mL, Fisher Scientific). The 
macrophages were incubated at 37°C, with 5% CO2 in either 96-well or 24-well tissue 
culture plates for 16-18 hours. A total of 6.0 x 106 macrophages were maintained in each 
plate at 1 mL per well. Macrophages were also activated with 1 ng/mL 
lipopolysaccharides (Sigma Aldrich) and 10 ng/mL interferon gamma for 16-18 hours.  
Nitrite Assay 
 
The level of nitrite is measured as an indicator for nitric oxide production.  
RAW264.7 cells, without or with activation by 1 ng/mL LPS and 10 μg/mL IFN-y in 
phenol-free DMEM (VWR), were seeded in either a 96-well or 24-well tissue culture 
plate (6 x 106 cells per plate). The cells were treated with varying concentrations of 
propionate (0, 0.1, or 1 mM) for 3 or 16-18 hours (see Table 1 below for detailed 
organization of the treatments used).  Nitric oxide (NO) production of these cells were 
determined by measuring the nitrite concentration in the cell culture media. Briefly, 100 
μl of cell culture supernatant was mixed with 100 μl of Griess reagent (1:1 of 1% [wt/vol] 
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sulfanilamide in water and 0.1% [wt/vol] naphthyl ethylenediamine dihydrochloride in 
10% [vol/vol] hydrochloric acid), which is made fresh on a weekly basis. The absorbance 
was measured at 560 nm after incubation at room temperature for 5 minutes using a 96-
well plate reader (BioTek). A sodium nitrite (NaNO2) standard curve was used to 
calculate nitrite concentrations in the samples.  
 
Cells Treatments Treatment Options 
Listeria Oxygen level Aerobic or Anaerobic 
Macrophage Activation ± IFNγ/LPS 
 Propionate 0, 0.1, 1, or 10 mM 
 Duration of propionate treatment 3 or 16-18 hours 
 
Table 1. Different treatments of L. monocytogenes and macrophages to assess the effects of 
propionate on the phagocytic activities of macrophages against L. monocytogenes.  
 
Gentamicin Protection Assay 
Gentamicin Protection Assays were used to determine the intracellular colony 
forming units (CFU) and percent survival of aerobically or anaerobically cultured L. 
monocytogenes within macrophages. RAW264.7 macrophage cells were seeded at 6 x 
106 cells per plate concentration in a 24-well tissue culture plate and were activated with 
1 mg/mL LPS and 10 ng/mL IFN-ɣ for 16-18 hours overnight. The next day, the DMEM 
was removed from all of the wells and new phenol red-free DMEM was added with 
either 0, 1, or 10 mM propionate treatments. The cells were incubated at 37°C for 3 hours 
with the additional propionate treatments and the overnight cultures of L. monocytogenes 
were prepared for infection. First, the L. monocytogenes cultures were washed with 
Dulbecco’s phosphate buffered saline (DPBS) and then they were normalized to a 
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multiplicity of infection of 10. This was achieved by diluting the cultures with calculated 
proportional volumes of DMEM. After the cells were treated with propionate for 3 hours, 
the DMEM was removed from the wells and 500 μl of either aerobically or anaerobically 
grown L. monocytogenes were added to infect the cells. After 30 minutes of infection, the 
cells were washed with DPBS (VWR) and 1 mL of 10 mg/mL gentamicin (VWR) 
DMEM mixture was added to each well to eliminate extracellular bacteria. At 2 hours 
post infection, the cells were lysed with sterile deionized water and 50 μl of the lysate 
was plated on LB media plates. After 2 days, the colonies of L. monocytogenes on each 
plate (CFU) were counted with a BioTek plate reader. 
Lactate Dehydrogenase (LDH) Assay 
LDH assays were performed to observe if propionate had any cytotoxic effect on 
the macrophage cells. RAW264.7 cells, with or without activation by IFN-y and LPS in 
phenol-free DMEM, were seeded in a 96-well plate for 16-18 hours. The cells were also 
treated with either 0, 0.1, or 1 mM propionate 16-18 prior to performing the assay. The 
assay was performed with a commercially available LDH assay kit from Fisher Scientific 
following manufacturer’s instructions. Briefly, 50 μl of the cell supernatant was 
transferred to a new 96-well plate and was combined with 50 μl of assay buffer. After 30 
minutes of incubation, 50 μl of stop solution was added to the wells. Then, 150 μl of each 
sample was transferred to a 96 well plate and their absorbance was measured at 480 nm. 
For the lysis control of the assay, the original plate was used, and the liquid was aspirated 
from the wells. Then, the cells were washed with DPBS and 90 μl of diluted lysis buffer 
was added to the wells. After 45 minutes of incubation, 50 ul of the lysate was added to a 
new 96 well plate containing 50 μl of reaction mixture. After a 30-minute incubation, 50 
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μl of stop solution was added to the samples and the absorbance was measured at 490 nm 
and 680 nm.  Cell death was expressed as the percentage of total lysis and was calculated 
by (test LDH release - spontaneous release)/(maximum release - spontaneous release) x 
100.  
Results and Discussion  
Nitrite Assay  
To investigate the effect of propionate on macrophages, I first performed nitrite 
assays in the absence of L. monocytogenes infection. Nitrite assays were used to measure 
nitric oxide production (via nitrite concentration) of naive or activated macrophages that 
were treated with 0, 1, or 10 mM concentrations of propionate. Figure 2 shows the 
results of these assays that were performed across 4 independent experiments. It was 
observed that 16-18 hours of propionate treatment had no significant effect on the nitric 
oxide production of naive macrophages. Conversely, nitric oxide production was 
suppressed with increasing concentrations of propionate in activated macrophages. As 
nitric oxide production is correlated with increased antimicrobial activity of 
macrophages, these results suggest that in the absence of infection, propionate has no 
observed effect on the antimicrobial activity of naive macrophages. Moreover, propionate 
decreases the antimicrobial activity of activated macrophages. These findings tell us that 
propionate may not be a good supplement to use before infection, as it is shown here to 
decrease the antimicrobial activity of macrophages. This is likely due to the anti-
inflammatory nature of propionate depressing our immune response and therefore 
reducing the amount of nitric oxide produced by macrophages.  




Figure 2 Nitrite concentration of naive and activated macrophages after propionate treatment for 
16-18 hours. Activated macrophages were also treated with LPS and IFN-γ overnight (16-18 
hours). These experiments were conducted in a 96-well plate with 4 replicates for each treatment. 
This graph shows averages of data from 4 independent experiments. 
 
LDH Assay  
To ensure that the decrease in nitric oxide production was not a result of 
propionate causing cell death or cytotoxicity to macrophage cells, LDH assays were 
performed. LDH is used as an indicator for cytotoxicity as it is released into the cell 
supernatant when the cell’s plasma membrane is damaged (citation). Figure 3 shows the 
results of an LDH assay performed in a 96-well plate with 4 replicates of each condition. 
This graph also consists of data averaged across 3 independent experiments. I observed 
that for naïve macrophages, the 1 mM propionate treatment significantly increased the 
amount of released LDH. In contrast, propionate treatment did not significantly affect the 
amount of released LDH. These results suggest that propionate treatment may cause 
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some cytotoxicity for naive macrophages. This data contradicts previous findings in our 
lab, that showed propionate concentrations up to 25 mM had no cytotoxic effect on 
macrophage cells. In the future, this experiment should be repeated to test the accuracy of 
this finding.  
 
Figure 3 LDH activity of macrophages after propionate treatment for 16-18 hours. Activated 
macrophages were also treated with LPS and IFN-γ overnight (16-18 hours). This graph is 
composed of data taken from 3 independent experiments.  
 
Nitrite Assay with Infection  
To establish the effect of propionate on immune cells during an infection, we first 
pre-treated naive and activated macrophages for 3 hours with propionate. After pre-
treatment, these macrophages were infected with aerobically or anaerobically grown L. 
monocytogenes and the nitric oxide production of the cells were measured via a nitrite 
assay performed at 24 hours post infection. Figure 4 demonstrates the results of these 
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experiments performed in a 24-well plate with 3 replicates each. It was noted that overall, 
3 hours of propionate pre-treatment prior to infection was not a sufficient amount of time 
to observe differences in the nitric oxide production of both naive and activated 
macrophages. However, infection with aerobic or anaerobic L. monocytogenes did 
contribute to changes in the nitric oxide production of both naive and activated 
macrophages. Specifically, in naive macrophages, those that were infected with aerobic 
bacteria had significantly decreased nitric oxide production then those that were infected 
with anaerobic bacteria. A similar effect was observed in activated macrophages, as the 
cells that were treated with aerobic bacteria also had significantly less nitric oxide 
production then those that were treated with anaerobic bacteria.  
Taken together, these results suggest macrophages that are infected with 
anaerobic L. monocytogenes produce more nitric oxide and have more antimicrobial 
activity then macrophages that are infected with aerobic L. monocytogenes. From this, it 
can be inferred that macrophages have the ability to differentiate between aerobic and 
anaerobic bacteria. To better understand this finding, more research needs to be 
conducted into the effects of oxygen exposure on the antimicrobial activity of 
macrophages. It will also be helpful to do more research into the different levels of 
oxygen that L. monocytogenes and macrophages experience within the different 
environments of the gut microbiome. Lastly, if these experiments were replicated, I 
would treat the macrophages with propionate for longer than 3 hours prior to infection to 
see if there would be a stronger effect on the nitric oxide production of macrophages.  





Figure 4 Nitrite concentration of naive and activated macrophages infected with aerobic and 
anaerobic L. monocytogenes. Macrophage cells were seeded overnight with LPS and IFN-y for 
16-18 hours and treated the next day with propionate for 3 hours. After propionate treatment, 
cells were infected for 3 min and nitrite concentration measurements were recorded 24 hours post 
infection.  




Intracellular CFU of Infected Macrophages 
To investigate the effects of propionate on immune cells, we used naive and 
activated macrophages and assayed for intracellular bacterial CFU after a 3-hour pre-
treatment with propionate. Cells were infected with aerobically or anaerobically grown L. 
monocytogenes for 30 minutes and were plated 24 hours post infection. Figure 4 shows 
the CFU/well for each macrophage treatment. For both naive and activated macrophages 
it was observed that there was no significant difference in the CFU/well between the 
different propionate treatments tested. However, as presented in the first two graphs of 
the figure, we noticed that the CFU/well of naive macrophages was significantly greater 
than the CFU/well of activated macrophages that were treated with propionate. This data 
supports previous research, as activated macrophages are expected to have more 
antimicrobial activity than naive macrophages. With more antimicrobial activity, then 
these macrophages are able to engulf and kill more L. monocytogenes, resulting in the 
decreased amounts of CFU/well that were observed.  
 Additionally, the third graph of the figure shows that there was no significant difference 
in CFU/well when naive macrophages were infected with aerobic or anaerobic bacteria. 
This data implicates that the antimicrobial activity of macrophages is not changed when 
they encounter L. monocytogenes with different levels of oxygen exposure. There also is 
no significant difference between the treatments of this data, because of standard 
deviation and variation between the data recorded. Lastly, the fourth graph of this figure 
shows that the CFU/well of activated macrophages are significantly decreased when they 
are infected with anaerobic L. monocytogenes. This data correlates with the data from 
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figure 4, as the increased nitric oxide levels were also observed in activated macrophages 
that were infected with anaerobic L. monocytogenes. This data suggests that activated 
macrophages can enhance their immune response when they are exposed to anaerobic L. 
monocytogenes. With this data in mind, it would be important in clinical settings to treat 
infections by facultative pathogens such as L. monocytogenes differently than how 
infections by obligate pathogens may be treated.  
 
 











Figure 5 Intracellular CFU/well of naive and activated macrophages that were pre-treated with 
propionate for 3 hours. Macrophages were infected for 30 minutes with aerobically and 
anaerobically grown L. monocytogenes. Cells were plated at 24 hours post infection and were 
diluted serially diluted with sterile water by a factor of 1:1000. First two graphs compare the 
CFU/well of naive vs activated macrophages that were both infected with either aerobic or 
anaerobic bacteria. The second graphs compare the CFU/well of macrophages infected with 
aerobic vs anaerobic L. monocytogenes. For each treatment there were 3 triplicates, and the data 
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